OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
000320$19880.0056

Noroo Holdings Co Ltd

Commodity ChemicalsVerified

Noroo Holdings maintains a strong liquidity position with KRW 189.7 billion in cash and equivalents, supported by a current ratio of 1.83 and a low debt-to-equity ratio of 0.29. The company's price-to-book ratio of 0.41 and price-to-tangible-book ratio of 0.41 suggest a significant discount to its book value, potentially indicating undervaluation or asset-heavy operations. Profitability metrics show a return on equity (ROE) of 6.45% and a return on assets (ROA) of 2.53%, which are below the typical thresholds for high-performing chemical firms. The company's operating margin of 5.35% (calculated from operating income of KRW 66.3 billion on revenue of KRW 1.24 trillion) is in line with industry norms but leaves room for improvement in cost control and pricing power. Geographically, Noroo Holdings' revenue is concentrated in South Korea, with no disclosed international operations. The company operates a single business segment focused on commodity chemicals, which exposes it to raw material price volatility and cyclical demand shifts. The company's growth trajectory is stable, with revenue of KRW 1.24 trillion in the latest period. While no specific growth rate is provided, the company's operating cash flow of KRW 80.1 billion and free cash flow of KRW 37.3 billion indicate a capacity to fund operations and potentially reinvest in the business. Risk factors for Noroo Holdings include exposure to commodity price fluctuations and potential regulatory changes in the chemical industry. The company's liquidity risk is low, with a strong cash position and manageable debt levels. However, the low ROE and ROA suggest that capital efficiency could be a concern. No immediate dilution risks are identified, with shares outstanding remaining stable at 10.25 million. Recent filings and transcripts do not highlight any material events or strategic shifts. The company's latest actual EPS of KRW 3,090 and revenue of KRW 1.24 trillion align with analyst expectations, indicating consistent performance.

30-day price · 000320(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyNoroo Holdings Co Ltd
Ticker000320.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Noroo Holdings Co Ltd is a South Korean company engaged in the production and sale of commodity chemicals, primarily serving industrial and manufacturing sectors.

Classification. Noroo Holdings is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Noroo Holdings maintains a strong liquidity position with KRW 189.7 billion in cash and equivalents, supported by a current ratio of 1.83 and a low debt-to-equity ratio of 0.29. The company's price-to-book ratio of 0.41 and price-to-tangible-book ratio of 0.41 suggest a significant discount to its book value, potentially indicating undervaluation or asset-heavy operations. Profitability metrics show a return on equity (ROE) of 6.45% and a return on assets (ROA) of 2.53%, which are below the typical thresholds for high-performing chemical firms. The company's operating margin of 5.35% (calculated from operating income of KRW 66.3 billion on revenue of KRW 1.24 trillion) is in line with industry norms but leaves room for improvement in cost control and pricing power. Geographically, Noroo Holdings' revenue is concentrated in South Korea, with no disclosed international operations. The company operates a single business segment focused on commodity chemicals, which exposes it to raw material price volatility and cyclical demand shifts. The company's growth trajectory is stable, with revenue of KRW 1.24 trillion in the latest period. While no specific growth rate is provided, the company's operating cash flow of KRW 80.1 billion and free cash flow of KRW 37.3 billion indicate a capacity to fund operations and potentially reinvest in the business. Risk factors for Noroo Holdings include exposure to commodity price fluctuations and potential regulatory changes in the chemical industry. The company's liquidity risk is low, with a strong cash position and manageable debt levels. However, the low ROE and ROA suggest that capital efficiency could be a concern. No immediate dilution risks are identified, with shares outstanding remaining stable at 10.25 million. Recent filings and transcripts do not highlight any material events or strategic shifts. The company's latest actual EPS of KRW 3,090 and revenue of KRW 1.24 trillion align with analyst expectations, indicating consistent performance.
Key takeaways
  • Noroo Holdings has a strong liquidity position with KRW 189.7 billion in cash and a current ratio of 1.83.
  • The company's price-to-book ratio of 0.41 suggests it is trading at a significant discount to its book value.
  • Return on equity of 6.45% and return on assets of 2.53% indicate moderate profitability relative to industry standards.
  • The company's operations are concentrated in South Korea with no disclosed international presence.
  • No immediate liquidity or dilution risks are identified, and the company's financials align with analyst expectations.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$1.24T
Gross profit$299.64B
Operating income$66.31B
Net income$32.42B
R&D
SG&A
D&A
SBC
Operating cash flow$80.06B
CapEx-$28.11B
Free cash flow$37.26B
Total assets$1.28T
Total liabilities$776.59B
Total equity$502.77B
Cash & equivalents$189.72B
Long-term debt$147.66B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.24T$66.31B$32.42B$37.26B
FY-1$1.25T$72.39B$50.90B$69.42B
FY-2$1.21T$66.29B$25.46B$42.59B
FY-3$1.04T$45.07B$24.97B$15.01B
FY-4$955.21B$27.16B$1.60B$512.4M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$1.28T$502.77B$189.72B
FY-1$1.21T$470.17B$132.44B
FY-2$1.19T$413.62B$143.27B
FY-3$1.17T$393.77B$113.60B
FY-4$1.06T$368.11B$126.64B
PeriodOCFCapExFCFSBC
FY0$80.06B-$28.11B$37.26B
FY-1$71.27B-$20.30B$69.42B
FY-2$97.51B-$20.83B$42.59B
FY-3$48.37B-$30.65B$15.01B
FY-4$25.40B-$20.35B$512.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$298.79B
FQ-1$286.80B$10.31B$7.69B$10.79B
FQ-2$314.72B$20.12B$10.73B$16.55B
FQ-3$348.83B$23.62B$7.78B-$478.2M
FQ-4$288.91B$12.26B$6.22B$10.64B
FQ-5$315.02B$3.32B$8.82B$10.91B
FQ-6$307.22B$23.75B$23.93B$32.98B
FQ-7$345.84B$28.36B$11.59B$8.01B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$508.60B$145.91B
FQ-1$1.28T$502.77B$189.72B
FQ-2$1.26T$485.76B$136.05B
FQ-3$1.24T$471.27B$108.12B
FQ-4$1.22T$470.69B$116.18B
FQ-5$1.21T$470.17B$132.44B
FQ-6$1.21T$452.03B$127.49B
FQ-7$1.22T$431.97B$110.18B
PeriodOCFCapExFCFSBC
FQ0-$19.06B-$6.98B
FQ-1$80.06B-$28.11B$10.79B
FQ-2$34.45B-$22.89B$16.55B
FQ-3$26.37B-$12.85B-$478.2M
FQ-4-$1.33B-$7.44B$10.64B
FQ-5$71.27B-$20.30B$10.91B
FQ-6$49.87B-$15.35B$32.98B
FQ-7$24.08B-$10.65B$8.01B
Valuation
Market price$19880.00
Market cap$203.74B
Enterprise value$161.68B
P/E6.3
Reported non-GAAP P/E
EV/Revenue0.1
EV/Op income2.4
EV/OCF2.0
P/B0.4
P/Tangible book0.4
Tangible book$502.77B
Net cash$42.06B
Current ratio1.8
Debt/Equity0.3
ROA2.5%
ROE6.5%
Cash conversion2.5%
CapEx/Revenue-2.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000320Activity
Op margin5.4%0.4% medp25 -8.0% · p75 16.0%above median
Net margin2.6%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin24.2%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity29.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS3,090.00 KRW
Last actual revenue1,239,268,000,000 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 02:32 UTCJob: bb3db2f8